List of works - Chun-Jen Liu

Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response.

scientific article published on 26 December 2016

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

scientific article

Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma.

scientific article published on 26 February 2018

Amebic liver abscess and human immunodeficiency virus infection: a report of three cases.

scientific article published on July 2001

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

scientific article published on 01 July 2002

Asian consensus on the relationship between obesity and gastrointestinal and liver diseases

scientific article

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

scientific article

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

scientific article published on 17 May 2012

Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus

scientific article

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

scientific article published on 19 November 2007

Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.

scientific article

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model

scientific article published on 13 June 2016

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma

scientific article published on 25 January 2019

Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma

scientific article

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

scientific article published in 2021

Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.

scientific article published in June 2003

Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure.

scientific article

Clinical presentations of patients from different age cohorts with biliary tract stone diseases

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

scientific article

Clinical significance of occult hepatitis B virus infection cannot be overlooked.

scientific article

Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.

scientific article published in January 2007

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

scientific article

Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals

scientific article published on 01 June 2014

Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

scientific article published on 10 November 2010

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.

scientific article

Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries

scientific article published on 27 June 2014

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

scientific article published on 24 June 2013

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

scientific article published on 16 September 2009

Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers

scientific article published on 04 July 2019

Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.

scientific article published on 13 April 2015

Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.

scientific article published in September 2006

Disease Progression in a Patient with Nonalcoholic Steatohepatitis

article

Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients

article

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection

scientific article published on 27 December 2018

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.

scientific article published on 9 July 2007

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.

scientific article

End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B.

scientific article

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

scientific article published on May 2006

Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

scientific article published on October 2012

Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C.

scientific article

Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.

scientific article

Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.

scientific article published on 30 March 2018

Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.

scientific article

Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.

scientific article published on 17 April 2018

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.

scientific article published on May 2013

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

scientific article published on 15 February 2009

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B

scientific article published on 01 January 2002

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

scientific article published in January 2004

Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels

scientific article published on 01 May 2007

Hepatitis B viral genotypes and lamivudine resistance.

scientific article published in February 2002

Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.

scientific article published in March 2009

Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.

scientific article published on 5 August 2009

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

scientific article published in January 2009

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

scientific article

Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management

scientific article published on 14 June 2011

Hepatitis C virus infection and increased risk of cerebrovascular disease.

scientific article published on 21 October 2010

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

scientific article published on 22 July 2022

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

scientific article published on 20 September 2010

High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users.

scientific article published in December 2004

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

scientific article

Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission ⬇️

scientific article published on July 21, 2011

Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.

scientific article published in April 2009

Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression

scientific article

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

scientific article published on 21 December 2016

Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection ⬇️

scientific article published on July 1, 2010

Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan

scientific article published on 01 October 2002

Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.

scientific article published on 27 July 2015

Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.

scientific article published on 12 July 2017

Influences of tobacco and alcohol use on hepatocellular carcinoma survival

scientific article published on 28 March 2012

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort ⬇️

scientific article published on April 3, 2011

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

scientific article published in April 2006

Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.

scientific article

Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients

scientific article published on 22 August 2016

Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area

scientific article published on 01 May 2006

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

scientific article

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

scientific article

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

scientific article

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

scientific article published on 4 April 2008

Metabolic syndrome on top of chronic hepatitis B: the more, the worse?

scientific article published on 01 February 2010

Milder clinical manifestation of scrub typhus in Kinmen, Taiwan

scientific article

Molecular Epidemiology of Hepatitis B Viral Serotypes and Genotypes in Taiwan

scientific article published on 01 March 2002

Molecular assays for hepatitis B virus infection.

scientific article published in November 2003

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis

scientific article

More than a virus: a qualitative study of the social implications of hepatitis B infection in China.

scientific article published on August 2017

Mother-to-infant transmission of hepatitis B virus: challenges and perspectives.

scientific article published on 24 October 2017

NOhep: Toward Global Control of Hepatitis B Virus Infection-An Introduction

scientific article published in November 2017

Natural course and treatment of hepatitis D virus infection.

scientific article published on November 2006

Origin of serum hepatitis B virus in acute exacerbation: comparison with HBV in the liver and from other exacerbation.

scientific article published in August 2004

Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants

scientific article published on 01 June 2006

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis

scientific article published on 27 May 2019

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses

scientific article published on 29 October 2008

Perspectives on dual hepatitis B and C infection in Taiwan

scientific article (publication date: May 2016)

Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan

scientific article published on 3 June 2014

Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.

scientific article published in April 2005

Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.

scientific article published on October 2012

Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma.

scientific article

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis

scientific article

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant.

scientific article

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.

scientific article published on 14 September 2015

Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.

scientific article published on 10 October 2008

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients

scientific article published in March 2003

Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk

scientific article published on 01 December 2003

Sequential combination therapy for chronic hepatitis B: more challenges to be tackled

scientific article published on 01 July 2007

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

scientific article published in August 2005

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

scientific article published on 28 April 2011

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

scientific article published on 17 November 2011

Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.

scientific article published on 31 August 2017

Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition

scientific article published on 26 May 2015

Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.

scientific article

Subgenotypes of hepatitis B virus genotype C in Taiwan.

scientific article

The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.

scientific article

The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment

scientific article published on 3 July 2017

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

scientific article

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

scientific article published on 18 August 2010

The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.

scientific article published on 16 September 2008

The risky body mass index ranges for significant hepatitis B viral load: A campus-based study

scientific article published on 01 January 2012

Therapeutic implications of hepatitis B virus genotypes.

scientific article

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

scientific article

Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.

scientific article published on 15 May 2013

Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues

scientific article published on January 2014

Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.

scientific article published on March 2014

Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B.

scientific article published in November 2017

Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan.

scientific article published on 20 August 2009

List of works by Chun-Jen Liu

Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response.

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma.

Amebic liver abscess and human immunodeficiency virus infection: a report of three cases.

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

Asian consensus on the relationship between obesity and gastrointestinal and liver diseases

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma

Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.

Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure.

Clinical presentations of patients from different age cohorts with biliary tract stone diseases

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

Clinical significance of occult hepatitis B virus infection cannot be overlooked.

Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals

Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.

Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers

Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.

Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.

Disease Progression in a Patient with Nonalcoholic Steatohepatitis

Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.

End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B.

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C.

Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.

Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.

Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.

Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels

Hepatitis B viral genotypes and lamivudine resistance.

Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.

Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management

Hepatitis C virus infection and increased risk of cerebrovascular disease.

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users.

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission ⬇️

Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.

Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection ⬇️

Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan

Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.

Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.

Influences of tobacco and alcohol use on hepatocellular carcinoma survival

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort ⬇️

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.

Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients

Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

Metabolic syndrome on top of chronic hepatitis B: the more, the worse?